SMTL ID : 6h1s.1 (1 other biounit)

Structure of the BM3 heme domain in complex with fluconazole

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.95 Å

Oligo State

monomer

Ligands

1 x TPF: 2-(2,4-DIFLUOROPHENYL)-1,3-DI(1H-1,2,4-TRIAZOL-1-YL)PROPAN-2-OL(Non-covalent)

TPF.1: 11 residues within 4Å: Chain A: A.74, L.75, V.78, F.82, I.263, A.264, E.267, T.268, L.437, T.438 Ligands: HEM.2 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:L.75, A:V.78 Hydrogen bonds: A:T.268 Water bridges: A:T.438

1 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)

HEM.2: 26 residues within 4Å: Chain A: K.69, L.75, L.86, V.87, W.96, F.107, F.261, A.264, G.265, T.268, T.269, L.272, T.327, A.328, F.331, P.392, F.393, G.394, R.398, A.399, C.400, I.401, G.402, F.405, A.406 Ligands: TPF.1 20 PLIP interactions: 20 interactions with chain A, Hydrophobic interactions: A:V.87, A:F.107, A:F.261, A:F.261, A:A.264, A:L.272, A:A.328, A:F.393, A:I.401, A:F.405 Hydrogen bonds: A:R.398 Water bridges: A:K.69, A:K.69, A:S.332, A:S.332, A:S.332 Salt bridges: A:K.69, A:K.69, A:R.398 Metal complexes: A:C.400

4 x PO4: PHOSPHATE ION(Non-functional Binders)

PO4.3: 4 residues within 4Å: Chain A: H.388, K.391, N.395, G.396 7 PLIP interactions: 7 interactions with chain A Hydrogen bonds: A:N.395, A:G.396 Water bridges: A:H.388, A:H.388, A:N.395 Salt bridges: A:H.388, A:K.391 PO4.4: 6 residues within 4Å: Chain A: R.223, E.228, Q.229, S.230, D.231, T.235 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:E.228, A:S.230, A:D.231, A:T.235, A:T.235 Salt bridges: A:R.223 PO4.5: 1 residues within 4Å: Chain A: K.289 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:K.289 PO4.6: 2 residues within 4Å: Chain A: E.137, H.138 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:H.138, A:H.138, A:H.138 Water bridges: A:H.138, A:H.138 Salt bridges: A:H.138

4 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.7: 3 residues within 4Å: Chain A: T.22, D.23, K.24 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:T.22, A:D.23, A:K.24, A:K.24 Water bridges: A:D.23, A:D.23 EDO.8: 5 residues within 4Å: Chain A: D.68, W.90, T.91, H.92, Y.334 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:T.91, A:H.92, A:H.92 EDO.9: 6 residues within 4Å: Chain A: W.130, E.131, L.133, A.448, K.449, S.450 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:W.130, A:L.133, A:S.450 EDO.10: 4 residues within 4Å: Chain A: V.308, K.309, H.408, T.411 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:K.309, A:H.408, A:T.411 Water bridges: A:H.408

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Jeffreys, L.N. et al., Novel insights into P450 BM3 interactions with FDA-approved antifungal azole drugs. Sci Rep (2019)

Release Date

2019-02-20

Peptides

Bifunctional cytochrome P450/NADPH--P450 reductase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Bifunctional cytochrome P450/NADPH--P450 reductase

Related Entries With Identical Sequence